Nsclc survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Cells, Cultured Lymph Nodes Lung Bile Ducts, Intrahepatic Mediastinum Cell Line

Organisms6

Mice, Inbred C57BL Mice, Nude Mice, Inbred BALB C Mice, Knockout Mice, SCID Mice, Transgenic

Diseases53

Adenocarcinoma Neoplasm Recurrence, Local Carcinoma, Squamous Cell Lymphatic Metastasis Lung Neoplasms Liver Neoplasms Disease Progression Carcinoma, Large Cell Breast Neoplasms Neoplasm Invasiveness Carcinoma, Hepatocellular Neoplasm Metastasis Recurrence Brain Neoplasms Postoperative Complications Carcinoma, Small Cell Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms Carcinoma Colorectal Neoplasms Esophageal Neoplasms Neoplasms Disease Models, Animal Bone Neoplasms Adenocarcinoma, Bronchiolo-Alveolar Bile Duct Neoplasms Rectal Neoplasms Heart Arrest Sarcoma Melanoma Cholangiocarcinoma Ovarian Neoplasms Head and Neck Neoplasms Kidney Neoplasms Prosthesis Failure Osteosarcoma Kidney Failure, Chronic Small Cell Lung Carcinoma Glioblastoma Nasopharyngeal Neoplasms Lymphoma, Non-Hodgkin Carcinoma, Adenosquamous Liver Failure Prostatic Neoplasms Neutropenia Skin Neoplasms Colonic Neoplasms Neovascularization, Pathologic Carcinoma, Renal Cell Mouth Neoplasms Cadaver Glioma

Chemicals and Drugs54

Antineoplastic Agents Cisplatin Tumor Markers, Biological Quinazolines Receptor, Epidermal Growth Factor Deoxycytidine Vinblastine Carboplatin Paclitaxel Protein Kinase Inhibitors Doxorubicin Fluorouracil Taxoids Vincristine Cyclophosphamide Etoposide Antimetabolites, Antineoplastic Antineoplastic Agents, Phytogenic RNA, Messenger Prednisone Neoplasm Proteins Antibodies, Monoclonal Proto-Oncogene Proteins Antibodies, Monoclonal, Humanized Vindesine Immunosuppressive Agents Ifosfamide Tumor Suppressor Protein p53 RNA, Small Interfering Guanine Glutamates Methotrexate Organoplatinum Compounds Mitomycin Camptothecin DNA, Neoplasm Ki-67 Antigen Tegafur Radiation-Sensitizing Agents Bleomycin Platinum Compounds ras Proteins Cryoprotective Agents Receptor, erbB-2 Platinum Tumor Suppressor Proteins Antineoplastic Agents, Alkylating Vascular Endothelial Growth Factor A Phosphatidylinositol 3-Kinases Dacarbazine Cytarabine DNA-Binding Proteins Protein-Serine-Threonine Kinases Pyrimidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment95

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Prognosis Retrospective Studies Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Neoplasm Staging Combined Modality Therapy Proportional Hazards Models Multivariate Analysis Immunohistochemistry Chemotherapy, Adjuvant Prospective Studies Risk Factors Actuarial Analysis Drug Administration Schedule Pneumonectomy Cohort Studies Liver Transplantation Radiotherapy Dosage Radiotherapy, Adjuvant Registries Predictive Value of Tests Hepatectomy Risk Assessment Remission Induction Lymph Node Excision Reoperation Chemoradiotherapy Reverse Transcriptase Polymerase Chain Reaction Neoadjuvant Therapy Kidney Transplantation Life Tables Tumor Burden Salvage Therapy Radiotherapy Dose Fractionation SEER Program Disease Models, Animal Transplantation, Homologous Chi-Square Distribution Incidence Patient Selection Palliative Care Gastrectomy Blotting, Western Clinical Trials as Topic Chemoembolization, Therapeutic Probability Cardiopulmonary Resuscitation Xenograft Model Antitumor Assays Gene Expression Profiling Treatment Failure Tissue Array Analysis Neoplasm Grading Analysis of Variance Cause of Death Clinical Trials, Phase III as Topic Tomography, X-Ray Computed Radiosurgery Cryopreservation Infusions, Intravenous Randomized Controlled Trials as Topic Immunoenzyme Techniques Preoperative Care Prosthesis Failure Esophagectomy Radiotherapy, High-Energy Molecular Targeted Therapy Radiotherapy, Conformal Severity of Illness Index Regression Analysis Brachytherapy Clinical Trials, Phase II as Topic Positron-Emission Tomography Feasibility Studies Pancreas Transplantation Dose-Response Relationship, Radiation Oligonucleotide Array Sequence Analysis Heart Transplantation Neoplasm Transplantation Case-Control Studies Transplantation, Autologous Cranial Irradiation Prosthesis Design Postoperative Care Statistics, Nonparametric Chemoradiotherapy, Adjuvant Polymerase Chain Reaction Induction Chemotherapy Transplantation, Heterologous In Situ Hybridization, Fluorescence

Phenomena and Processes28

Cell Survival Graft Survival Time Factors Apoptosis Gene Expression Regulation, Neoplastic Cell Proliferation Signal Transduction Mutation Drug Resistance, Neoplasm Graft Rejection Dose-Response Relationship, Drug Chi-Square Distribution Probability Tissue Survival Phosphorylation Genes, erbB-1 Gene Expression Up-Regulation Microbial Viability Dose-Response Relationship, Radiation Cell Division Cell Death Down-Regulation Cell Movement RNA Interference Drug Synergism Radiation Tolerance Longevity

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Life Tables SEER Program Incidence Cause of Death Radiotherapy, Conformal

Named Groups4

Tissue Donors Infant, Newborn Living Donors Survivors

Health Care40

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Risk Factors Actuarial Analysis Age Factors Cohort Studies Registries Predictive Value of Tests Risk Assessment Life Tables SEER Program Chi-Square Distribution Incidence Patient Selection Palliative Care Clinical Trials as Topic Probability Treatment Failure Analysis of Variance Cause of Death Clinical Trials, Phase III as Topic Randomized Controlled Trials as Topic Sex Factors Preoperative Care Severity of Illness Index Regression Analysis Clinical Trials, Phase II as Topic Feasibility Studies Dose-Response Relationship, Radiation Case-Control Studies Postoperative Care Statistics, Nonparametric

Geographicals3

Japan United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Survival Analysis Disease-Free Survival Treatment Outcome Prognosis Survival Retrospective Studies Graft Survival Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Time Factors Neoplasm Staging Combined Modality Therapy Proportional Hazards Models Adenocarcinoma Neoplasm Recurrence, Local Antineoplastic Agents Cisplatin Tumor Markers, Biological Cell Line, Tumor Carcinoma, Squamous Cell Multivariate Analysis Lymphatic Metastasis Immunohistochemistry Lung Neoplasms Apoptosis Liver Neoplasms Chemotherapy, Adjuvant Quinazolines Prospective Studies Risk Factors Disease Progression Carcinoma, Large Cell Receptor, Epidermal Growth Factor Deoxycytidine Gene Expression Regulation, Neoplastic Vinblastine Actuarial Analysis Drug Administration Schedule Carboplatin Paclitaxel Pneumonectomy Age Factors Cohort Studies Liver Transplantation Radiotherapy Dosage Breast Neoplasms Neoplasm Invasiveness Cell Proliferation Carcinoma, Hepatocellular Radiotherapy, Adjuvant Neoplasm Metastasis Recurrence Brain Neoplasms Signal Transduction Protein Kinase Inhibitors Postoperative Complications Mutation Registries Carcinoma, Small Cell Predictive Value of Tests Hepatectomy Doxorubicin Stomach Neoplasms Risk Assessment Drug Resistance, Neoplasm Carcinoma, Non-Small-Cell Lung Fluorouracil Taxoids Remission Induction Vincristine Cyclophosphamide Lymph Node Excision Reoperation Etoposide Chemoradiotherapy Reverse Transcriptase Polymerase Chain Reaction Neoadjuvant Therapy Kidney Transplantation Pancreatic Neoplasms Carcinoma Life Tables Antimetabolites, Antineoplastic Colorectal Neoplasms Esophageal Neoplasms Tumor Burden Salvage Therapy Graft Rejection Radiotherapy Dose-Response Relationship, Drug Dose Fractionation Neoplasms SEER Program Disease Models, Animal Mice, Inbred C57BL Bone Neoplasms Transplantation, Homologous Antineoplastic Agents, Phytogenic

No FAQ available that match "nsclc survival rate"